Deep Brain Stimulation for Treatment-Resistant Depression: Follow-Up After 3 to 6 Years
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Objective A prevalence of at least 30% for treatment-resistant depression has prompted the investigation of alternative treatment strategies. Deep brain stimulation (DBS) is a promising targeted approach involving the bilateral placement of electrodes at specific neuroanatomical sites. Given the invasive and experimental nature of DBS for treatment-resistant depression, it is important to obtain both short-term and long-term effectiveness and safety data. This report represents an extended follow-up of 20 patients with treatment-resistant depression who received DBS to the subcallosal cingulate gyrus (Brodmann's area 25). Method After an initial 12-month study of DBS, patients were seen annually and at a last follow-up visit to assess depression severity, functional outcomes, and adverse events. Results The average response rates 1, 2, and 3 years after DBS implantation were 62.5%, 46.2%, and 75%, respectively. At the last follow-up visit (range=3-6 years), the average response rate was 64.3%. Functional impairment in the areas of physical health and social functioning progressively improved up to the last follow-up visit. No significant adverse events were reported during this follow-up, although two patients died by suicide during depressive relapses. Conclusions These data suggest that in the long term, DBS remains a safe and effective treatment for treatment-resistant depression. Additional trials with larger samples are needed to confirm these findings.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another study showed progressive improvement in the domain of social functioning up to three years after deep brain stimulation (Kennedy et al., 2011).”
From Social functioning in major depressive disorder (2016) · cites this paper as Kennedy et al., 2011
In the citing paper
“The first open-label trial of DBS for TRD conducted by Mayberg et al. demonstrated its safety and efficacy, with a response rate (RS) at 6 months of 66% and remission (RM) rate of 33% [5].”
From Deep brain stimulation for depression. (2022) · cites this paper as [24]
Citations
Cites
(1992) · PubMed · Cited by 33,716
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817 · cited 1×
“In the latter group, the response rate was 60% (with response defined as a decrease of ≥50% in total score on the 17-item Hamilton Depression Rating Scale [HAM-D] [9]) and the remission rate was 30% (with remission defined as a HAM-D score ≤7).”
MethodThe MOS 36-ltem Short-Form Health Survey (SF-36): I. Conceptual Framework and Item Selection
Ware, J. E., & Sherbourne, C. D. (1992) · Medical Care · doi:10.1097/00005650-199206000-00002 · Cited by 30,033
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Nierenberg, A. A., Stewart, J. W., Warden, D., Niederehe, G., Thase, M. E., Lavori, P. W., Lebowitz, B. D., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.11.1905 · Cited by 5,643
Deep Brain Stimulation for Treatment-Resistant Depression
Mayberg, H. S., Lozano, A. M., Voon, V., McNeely, H. E., Seminowicz, D., Hamani, C., Schwalb, J. M., & Kennedy, S. H. (2005) · Neuron · doi:10.1016/j.neuron.2005.02.014 · Cited by 4,059 · cited 6×
“In summary, the rates of antidepressant response observed over 3 years of DBS are consistent with those previously reported (7, 8).”
BackgroundMethodResultInfluentialSelf-citationDeep Brain Stimulation to Reward Circuitry Alleviates Anhedonia in Refractory Major Depression
Schlaepfer, T. E., Cohen, M. X., Frick, C., Kosel, M., Brodesser, D., Axmacher, N., Joe, A. Y., Kreft, M., Lenartz, D., & Sturm, V. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301408 · Cited by 1,027 · cited 1×
“Most but not all studies (23) have reported that lower voltages are associated with better clinical results.”
BackgroundSubcallosal cingulate gyrus deep brain stimulation for treatment-resistant depression
Lozano, A. M., Mayberg, H. S., Giacobbe, P., Hamani, C., Craddock, R. C., & Kennedy, S. H. (2008) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.05.034 · Cited by 1,024 · cited 5×
“No device-related adverse events occurred beyond those previously reported up to 1 year (8).”
BackgroundMethodResultInfluentialSelf-citationDeep Brain Stimulation of the Ventral Capsule/Ventral Striatum for Treatment-Resistant Depression
Malone, D. A., Dougherty, D. D., Rezai, A. R., Carpenter, L. L., Friehs, G. M., Eskandar, E. N., Rauch, S. L., Rasmussen, S. A., Machado, A. G., Kubu, C. S., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.08.029 · Cited by 897 · cited 4×
“Malone and colleagues (13) reported response rates of 40% and 53.”
BackgroundInfluentialAffective disorders and suicide risk: a reexamination
Bostwick, J. M., & Pankratz, V. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.12.1925 · Cited by 878
Bewernick, B. H., Hurlemann, R., Matusch, A., Kayser, S., Grubert, C., Hadrysiewicz, B., Axmacher, N., Lemke, M., Cooper-Mahkorn, D., Cohen, M. X., et al. (2010) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.09.013 · Cited by 865 · cited 4×
“Other investigators have used different neuroanatomical targets for stimulation, including the ventral capsule/ventral striatum (13) and the nucleus accumbens (14).”
BackgroundInfluential(1997) · PubMed · Cited by 727
Suicide and Primary Affective Disorders
Guze, S. B., & Robins, E. (1970) · British Journal of Psychiatry · doi:10.1192/bjp.117.539.437 · Cited by 724 · cited 1×
“The rate of suicide in depressed patients is frequently cited as 15% (29), based on a follow-up study of severely ill hospitalized patients with a diagnosis of “melancholic depression.”
BackgroundJohansen-Berg, H., Gutman, D. A., Behrens, T. E. J., Matthews, P. M., Rushworth, M. F. S., Katz, E., Lozano, A. M., & Mayberg, H. S. (2008) · Cerebral Cortex · doi:10.1093/cercor/bhm167 · Cited by 561
Self-citationDeep brain stimulation for refractory obsessive-compulsive disorder
Abelson, J. L., Curtis, G. C., Sagher, O., Albucher, R. C., Harrigan, M., Taylor, S. F., Martis, B., & Giordani, B. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.11.042 · Cited by 522
Birnbaum, H. G., Kessler, R. C., Kelley, D., Ben-Hamadi, R., Joish, V. N., & Greenberg, P. E. (2010) · Depression and Anxiety · doi:10.1002/da.20580 · Cited by 380 · cited 1×
“All procedures were approved by the Research Ethics Board of Major depressive disorder presents a substantial health burden worldwide (1, 2), and at least 30% of patients demonstrate treatment resistance to antidepressants (3).”
MethodThe Long-Term Outcome of Maudsley Depressives
Lee, A. S., & Murray, R. M. (1988) · British Journal of Psychiatry · doi:10.1192/bjp.153.6.741 · Cited by 318 · cited 1×
“The long-term outcome of depressed patients is characterized by high rates of medical comorbidity and mortality from both suicide and medical illness (25, 26), with all-cause mortality rates in treatment-resistant depression estimated in two studies to be 13% over 4–8 years (27) and 32% over 7 years (28).”
BackgroundEffect on mood of subthalamic DBS for Parkinson’s disease A consecutive series of 24 patients
Berney, A., Vingerhoets, F., Perrin, A., Guex, P., Villemure, J.-G., Burkhard, P. R., Benkelfat, C., & Ghika, J. (2002) · Neurology · doi:10.1212/01.wnl.0000032756.14298.18 · Cited by 310
Fekadu, A., Wooderson, S. C., Markopoulo, K., Donaldson, C., Papadopoulos, A., & Cleare, A. J. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.10.014 · Cited by 299 · cited 1×
“Treatment-resistant depression has been associated with poor clinical outcomes (17) and impaired longterm social functioning (18).”
BackgroundAppleby, B. S., Duggan, P. S., Regenberg, A., & Rabins, P. V. (2007) · Movement Disorders · doi:10.1002/mds.21551 · Cited by 291
The burden of disease for treatment-resistant depression.
Greden, J. F. (2001) · PubMed · Cited by 279
Suicide and Family Loading for Affective Disorders
Egeland, J. A. (1985) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1985.03360070053022 · Cited by 241
Hu, X. H., Bull, S. A., Hunkeler, E. M., Ming, E., Lee, J. Y., Fireman, B., & Markson, L. E. (2004) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v65n0712 · Cited by 235 · cited 1×
“Adverse events are a common reason for treatment discontinuation in major depression (22).”
BackgroundDunner, D. L., Rush, A. J., Russell, J. M., Burke, M., Woodard, S., Wingard, P., & Allen, J. (2006) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v67n0501 · Cited by 234
A tractography analysis of two deep brain stimulation white matter targets for depression
Gutman, D. A., Holtzheimer, P. E., Behrens, T. E. J., Johansen-Berg, H., & Mayberg, H. S. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.09.021 · Cited by 220 · cited 1×
“This raises the possibility that stimulation at multiple target sites may influence activity at different points of the neurocircuitry subserving emotion regulation (15, 16).”
BackgroundSelf-citationSuicide after successful deep brain stimulation for movement disorders
Burkhard, P. R., Vingerhoets, F. J. G., Berney, A., Bogousslavsky, J., Villemure, J.-G., & Ghika, J. (2004) · Neurology · doi:10.1212/01.wnl.0000145603.48221.b5 · Cited by 219
Residual symptoms at remission from depression: Impact on long-term outcome
Kennedy, N., & Paykel, E. S. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(03)00054-5 · Cited by 199 · cited 1×
“Treatment-resistant depression has been associated with poor clinical outcomes (17) and impaired longterm social functioning (18).”
BackgroundElectroconvulsive Therapy: Part I. A Perspective on the Evolution and Current Practice of ECT
Payne, N. A., & Prudic, J. (2009) · Journal of Psychiatric Practice · doi:10.1097/01.pra.0000361277.65468.ef · Cited by 178 · cited 1×
“While ECT has a robust evidence base for efficacy, access and tolerability issues have restricted its use (5).”
BackgroundKim, C. D., Seguin, M., Therrien, N., Riopel, G., Chawky, N., Lesage, A. D., & Turecki, G. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.5.1017 · Cited by 178
Bronisch, T., & Wittchen, H. U. (1994) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02193525 · Cited by 164
Hamani, C., Mayberg, H., Snyder, B., Giacobbe, P., Kennedy, S., & Lozano, A. M. (2009) · Journal of neurosurgery · doi:10.3171/2008.10.jns08763 · Cited by 160 · cited 1×
“However, in an extension of the preliminary findings by our group (11, 24), long-term antidepressant outcome was not predicted by stimulation parameters or regional variation in the placement of electrodes in the subcallosal cingulate gyrus.”
BackgroundSelf-citationPatten, S. B., Kennedy, S. H., Lam, R. W., O'Donovan, C., Filteau, M. J., Parikh, S. V., & Ravindran, A. V. (2009) · Journal of Affective Disorders · doi:10.1016/j.jad.2009.06.044 · Cited by 148 · cited 1×
“All procedures were approved by the Research Ethics Board of Major depressive disorder presents a substantial health burden worldwide (1, 2), and at least 30% of patients demonstrate treatment resistance to antidepressants (3).”
MethodSelf-citationMcNeely, H. E., Mayberg, H. S., Lozano, A. M., & Kennedy, S. H. (2008) · Journal of Nervous & Mental Disease · doi:10.1097/nmd.0b013e3181710927 · Cited by 146 · cited 1×
“We previously reported no negative neuropsychological effects of subcallosal cingulate gyrus DBS in the first six patients of this series up to 12 months after DBS implantation (19).”
BackgroundSelf-citationGlobal burden of depressive disorders: The issue of duration
Üstün, T. B., & Kessler, R. C. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.181.3.181 · Cited by 125 · cited 1×
“From a public health point of view, both the duration and the severity of illness are important determinants of the disease burden of major depression (20).”
BackgroundGiacobbe, P., Mayberg, H. S., & Lozano, A. M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.028 · Cited by 112 · cited 1×
“This raises the possibility that stimulation at multiple target sites may influence activity at different points of the neurocircuitry subserving emotion regulation (15, 16).”
BackgroundSelf-citationTreatment Resistant Depression— Advances in Somatic Therapies
Kennedy, S. H., & Giacobbe, P. (2007) · Annals of Clinical Psychiatry · doi:10.1080/10401230701675222 · Cited by 104 · cited 1×
“Nevertheless, there has been growing interest in different neurostimulation options over the past decade (6).”
BackgroundSelf-citationSeven Year Prognosis in Depression: Mortality and Readmission Risk in the Nottingham ECT Cohort
O'Leary, D. A., & Lee, A. S. (1996) · British Journal of Psychiatry · doi:10.1192/bjp.169.4.423 · Cited by 92
Outcome in refractory depression
Shergill, S. S., Robertson, M. M., Stein, G. S., Bernadt, M., & Katona, C. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00201-8 · Cited by 15
Depression in the medically Ill: Diagnostic and therapeutic implications
Narasimhan, M., Raynor, J. D., & Jones, A. B. (2008) · Current Psychiatry Reports · doi:10.1007/s11920-008-0044-z · Cited by 14 · cited 1×
“The long-term outcome of depressed patients is characterized by high rates of medical comorbidity and mortality from both suicide and medical illness (25, 26), with all-cause mortality rates in treatment-resistant depression estimated in two studies to be 13% over 4–8 years (27) and 32% over 7 years (28).”
Background
Research works printed but not linked: 3
- Thase ME, 1997, J Clin Psychiatry, 58, 23
- Greden JF, 2001, J Clin Psychiatry, 62, 26
- Helgason T, 1979, Origin, Prevention, and Treatment of Affective Disorders, 241
Cited by
Interoceptive predictions in the brain
Barrett, L. F., & Simmons, W. K. (2015) · Nature Reviews Neuroscience · doi:10.1038/nrn3950 · Cited by 1,766
Berridge, K. C., & Kringelbach, M. L. (2015) · Neuron · doi:10.1016/j.neuron.2015.02.018 · Cited by 1,730
“Similarly, relief from anxiety or depression may be produced by some deep brain stimulations of the NAc or prefrontal cortex, resulting in positive engagement in social or leisure activities (Bewernick et al., 2010; Kennedy et al., 2011).”
BackgroundDeep brain stimulation: current challenges and future directions
Lozano, A. M., Lipsman, N., Bergman, H., Brown, P., Chabardes, S., Chang, J. W., Matthews, K., McIntyre, C. C., Schlaepfer, T. E., Schulder, M., et al. (2019) · Nature Reviews Neurology · doi:10.1038/s41582-018-0128-2 · Cited by 1,450
Self-citationTreatment-resistant depression: therapeutic trends, challenges, and future directions
Al-harbi (2012) · Patient Preference and Adherence · doi:10.2147/ppa.s29716 · Cited by 796
“Data from a follow-up study suggested that in the long term (up to 6 years), DBS remains a safe and effective treatment for treatment-resistant depression.(120) Finally, psychosurgery, such as subcaudate tractotomy, limbic leucotomy, anterior capsulotomy, and anterior cingulotomy remain the last line of somatic treatm…”
Probing and regulating dysfunctional circuits using deep brain stimulation
Lozano, A. M., & Lipsman, N. (2013) · Neuron · doi:10.1016/j.neuron.2013.01.020 · Cited by 665
“At 3 years follow-up, response and remission rates were 60% and 50%, respectively (Kennedy et al., 2011).”
Self-citation
Metadata
- Authors
- Kennedy, S. H., Giacobbe, P., Rizvi, S. J., Placenza, F. M., Nishikawa, Y., Mayberg, H. S., & Lozano, A. M.
- Affiliations
- University Health Network (CA)
- From the Department of Psychiatry and the Division of Neurosurgery, Department of Surgery, University Health Network, Toronto; the Departments of Psychiatry, Pharmaceutical Sciences, and Neuroscience, University of Toronto; and the Departments of Psychiatry and Neurology, Emory University School of Medicine, Atlanta.
- Venue
- American Journal of Psychiatry
- Published
- 2011-05
- Volume
- 168
- Issue
- 5
- Pages
- 502-510
- ISSN
- 0002-953X (ISSN-L)
- 1535-7228
- OpenAlex
- W2140929483
- Cited by
- 481
- References
- 38
- Citations by year
- 2026: 12 · 2025: 14 · 2024: 24 · 2023: 28 · 2022: 23 · 2021: 25 · 2020: 20 · 2019: 24 · 2018: 34 · 2017: 39 · 2016: 30 · 2015: 49 · 2014: 46 · 2013: 46 · 2012: 48
- FWCI
- 32.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Clinical Psychology › Obsessive-Compulsive Spectrum Disorders
- Keywords
- deep brain stimulation, treatment-resistant depression, long-term follow-up, treatment response, functional outcome, adverse events, suicide, depression relapse
- MeSH terms
- Adult, Analysis of Variance, Major Depressive Disorder, Follow-Up Studies, Gyrus Cinguli, Humans, Middle Aged, Psychiatric Status Rating Scales, Suicide, Time Factors, Chi-Square Distribution, Treatment Failure, Deep Brain Stimulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.